Apoptosis Inhibitor 5: A Multifaceted Regulator of Cell Fate
Biomolecules · 22.01.2024 · 14 (1) · 136
DOI: 10.3390/biom14010136 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 22.01.2024. Verfasst von Hafsia Abbas und 7 weiteren Autor:innen. Beteiligte Einrichtung: Université Oran 1, Ahmed Ben Bella, Oran 31000, Algeria. Hauptthemen laut MEDLINE: Apoptosis Regulatory Proteins, Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Inserm.
Abstract (Originalsprache)
Apoptosis, or programmed cell death, is a fundamental process that maintains tissue homeostasis, eliminates damaged or infected cells, and plays a crucial role in various biological phenomena. The deregulation of apoptosis is involved in many human diseases, including cancer. One of the emerging players in the intricate regulatory network of apoptosis is apoptosis inhibitor 5 (API5), also called AAC-11 (anti-apoptosis clone 11) or FIF (fibroblast growth factor-2 interacting factor). While it may not have yet the same level of notoriety as some other cancer-associated proteins, API5 has garnered increasing attention in the cancer field in recent years, as elevated API5 levels are often associated with aggressive tumor behavior, resistance to therapy, and poor patient prognosis. This review aims to shed light on the multifaceted functions and regulatory mechanisms of API5 in cell fate decisions as well as its interest as therapeutic target in cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Université Oran 1, Ahmed Ben Bella, Oran 31000, Algeria.
- Jalon Therapeutics, 75010 Paris, France.
- Laboratoire de Transfert des Leucémies, EA3518, Institut de Recherche Saint Louis, Hôpital Saint Louis, Université de Paris, 75010 Paris, France.
- AP-HP, Service d'Hématologie Clinique, Hôpital Avicenne, Université Paris XIII, 93000 Bobigny, France.
- OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Hôpital Saint-Louis, 75010 Paris, France.
- INSERM UMRS976, Institut de Recherche Saint Louis, Hôpital Saint Louis, 75010 Paris, France.
ORCID-Profile: Jean-Luc Poyet
Förderung
- Inserm
Zitieren
APA
Abbas, H., Derkaoui, D. K., Jeammet, L., Adicéam, E., Tiollier, J., Sicard, H., Braun, T., & Poyet, J. L. (2024). Apoptosis Inhibitor 5: A Multifaceted Regulator of Cell Fate. Biomolecules, 14(1), 136. https://doi.org/10.3390/biom14010136
Vancouver
Abbas H, Derkaoui DK, Jeammet L, Adicéam E, Tiollier J, Sicard H, et al. Apoptosis Inhibitor 5: A Multifaceted Regulator of Cell Fate. Biomolecules. 2024;14(1):136. doi:10.3390/biom14010136
BibTeX
@article{Abbas2024,
author = {Abbas, Hafsia and Derkaoui, Dalia Kheira and Jeammet, Louise and Adicéam, Emilie and Tiollier, Jérôme and Sicard, Hélène and Braun, Thorsten and Poyet, Jean-Luc},
title = {Apoptosis Inhibitor 5: A Multifaceted Regulator of Cell Fate},
journal = {Biomolecules},
year = {2024},
volume = {14},
number = {1},
pages = {136},
doi = {10.3390/biom14010136}
}
EUVIMED